Tiziana Russo Spena | Pharmaceutical Biotechnology | Best Paper Award

Published on by Top Pharmaceutical

Tiziana Russo Spena | Pharmaceutical Biotechnology | Best Paper Award

Prof. Tiziana Russo Spena, Dipartimento di Economia management Istituzioni, Università degli Studi di Napoli Federico II, Italy

Prof. Tiziana Russo Spena is a Full Professor of Economics and Business Management at the University of Naples Federico II 🇮🇹. She holds a Ph.D. in Business Economics and specializes in digital health, sustainable business models, and stakeholder engagement 🔬💡. She has led multiple national and international research projects, including initiatives on blockchain in the agri-food sector, interactive robotics for aging well, and digital health services 🤖🌿. With extensive academic contributions, she plays a key role in shaping innovative business strategies and economic frameworks. 📚🏆

Publication Profile

Scopus

Education

Prof. Tiziana Russo Spena 🎓 is a distinguished Full Professor of Economics and Business Management (2022). She earned her Ph.D. in Business Economics (2002-2005) from the Faculty of Economics, University of Naples Federico II. Prior to that, she completed a Master’s in Investment Project Evaluation (2002) at the Research Centre of Urban and Territorial Management (L.U.P.T). Her academic journey began with a Degree in Business and Administration (1998), graduating with top honors (110/110 cum laude) from the same university. With a strong foundation in business and economics, she has made remarkable contributions to the field. 📚💼

Institutional And Membership

Prof. Tiziana Russo Spena 🎓 is an active member of the academic and research community, contributing to various institutional and membership activities. In 2024, she joined the Editorial Board of the International Journal of Research in Marketing and became the Coordinator of the Ph.D. Program in Management at the University of Naples Federico II. She serves as a board member of ReSER and CAISIAL, a treasurer at ReSER, and a key member of the Ateneo Commission for Internationalization. Additionally, she co-founded the Italian Blockchain National Observatory and leads advanced training courses in social media marketing and blockchain. 🔗📚

Awards

Prof. Tiziana Russo Spena 🏆 has received numerous prestigious awards for her research and contributions. In 2022, her article on COVID-19’s impact won the Highly Commended Paper award. She earned the Outstanding Paper Award (2013) for her work on store experience and co-creation. Her research on food innovation won the Best Paper Award (2013) at Lucerne University. Recognized as a Pioneer of Human Side of Service Engineering (2012), she was also a finalist in the Start Cup-Campania Competition (2011). Additionally, she received the Best Service Innovation Thinking Award (2008) and the Roberto Marrama Prize (2004). 🏅

Teaching Activities

Prof. Tiziana Russo Spena 🎓 has an extensive teaching career spanning various disciplines in business and management. Since 2019, she has been a Professor of Ethics and Management at the University of Naples Federico II. She also teaches Management (2018–present) and Marketing of Pharmaceutical Products (2012–present). Previously, she taught International Management (2013–2019), Retail Management (2013–2016), and International Marketing (2016–2018). She was a Visiting Professor in Brazil (2013) and an Assistant Professor at Magna Graecia University (1994–2012). Her contributions span agrifood, non-profits, and international trade, shaping future business leaders. 📚

Research Focus

Professor Tiziana Russo Spena specializes in service innovation, digital transformation, and customer experience, particularly in emerging digital ecosystems. Her research focuses on topics such as the phygital customer journey 🛍️📱, human-robot collaboration 🤖🤝, the metaverse in business and marketing 🌐🎭, and technology-enabled value co-creation 💡🔗. She explores how smart technologies and AI-driven solutions enhance consumer engagement and service management. Additionally, she investigates the role of innovation ecosystems in cultural heritage 🏛️📜. Her interdisciplinary approach integrates marketing, digital services, and technology management, shaping the future of service design and digital customer interactions.

Publication Top Notes

Unravelling the customer journey: A conceptual framework and research agenda

Phygital customer journey: a practice-based approach

A system and learning perspective on human–robot collaboration

Experimenting on the metaverse to foster innovation

HCAI-Based Service Provision for an Engaged University

Agencement of onlife and phygital: smart tech–enabled value co-creation practices

Innovative value propositions in the fashion metaverse

Addressing Socio-Material Issues for an Emerging Innovation Ecosystem: Insights From Cultural Heritage

Bo Meng | Pharmaceutical Biotechnology | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Bo Meng | Pharmaceutical Biotechnology | Top Pharmaceutical Scientist Award

Dr Bo Meng, WuXi Biologics, China

🔬 Dr. Bo Meng is an Associate Director at WuXi Biologics, Shanghai 🇨🇳 (2017–present), leading 30+ CMC projects for biologics like antibodies, enzymes, and vaccines. 💉 He manages a team of 20+ scientists, driving innovations from pre-IND to BLA filings. Previously, he was a Research Scientist at Omicron Biochemicals, USA 🇺🇸, focusing on glycan synthesis. 🧪 Dr. Meng earned his Ph.D. in Organic Chemistry from the University of Tennessee 🎓 and a B.Sc. in Applied Chemistry from Beijing Institute of Technology. 📖 His research is published in top journals, and he holds a Lean Six Sigma Green Belt. 🏆

Publication Profile

Orcid

Education

Dr. Bo Meng 🎓 earned a Ph.D. in Organic Chemistry 🧪 from the University of Tennessee, Knoxville 🇺🇸, completing his studies in August 2015. His academic journey began at Beijing Institute of Technology 🇨🇳, where he obtained a Bachelor’s degree in Applied Chemistry ⚗️ in June 2010. With a strong foundation in chemical sciences and research, Dr. Meng has developed expertise in organic synthesis and chemical applications. His educational background reflects a dedication to advancing scientific knowledge and contributing to innovative research in the field of chemistry 🔍🔬.

Working Experience

Dr. Bo Meng is the Associate Director at WuXi Biologics in Shanghai, China (2017–present) 🇨🇳🔬. With expertise in biologics development, he leads 30+ CMC projects, including antibodies, fusion proteins, ADCs, enzymes, vaccines, and mRNA 💉🧬. As Project Head, he oversees cell line development, process optimization, and regulatory filings from pre-IND to BLA 📑⚙️. He also manages a 20-person analytical team, ensuring robust assay development, product stability, and regulatory compliance. Previously, he worked at Omicron Biochemicals Inc. in the USA (2015–2017) 🇺🇸⚗️, contributing significantly to innovative biopharmaceutical advancements.

Research Scientist

Dr. Bo Meng specializes in the chemical and enzymatic synthesis, purification, and analysis of oligosaccharides 🧪, with a focus on high-mannose N-glycans, mannose phosphates, and 13C-labeled sugars 🧬. These complex carbohydrates play a crucial role as therapeutic targets in pathology and immunological studies 🩺🛡️. Through innovative research and advanced analytical techniques, Dr. Meng contributes to the development of new treatments and diagnostic tools for various diseases. Their work bridges the gap between biochemical research and medical applications, enhancing our understanding of immune responses and disease mechanisms for better healthcare solutions 🌱💡.

Research Focus

Dr. Bo Meng’s research spans biopharmaceuticals, carbohydrate chemistry, and materials science. 🧪🔬 His recent work investigates excipient impacts on polysorbate 80 degradation in biopharmaceutical formulations. 💉🧫 He has explored regioselective glycosylation to synthesize high-mannose oligosaccharides with mannose-6-phosphate residues. 🍬⚛️ Additionally, Dr. Meng has contributed to developing hyper-crosslinked cyclodextrin polymers for efficient CO₂ capture and catalytic applications. 🌿🛠️ His innovative work in carbohydrate-based materials showcases potential for green chemistry, biotechnology, and drug formulation. 🌏💊 Through interdisciplinary approaches, he advances solutions for environmental challenges and pharmaceutical stability. 📈🔍

Publication Top Notes

Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers

Synthesis of high-mannose oligosaccharides containing mannose-6-phosphate residues using regioselective glycosylation

Rapid assembly of branched mannose oligosaccharides through consecutive regioselective glycosylation: A convergent and efficient strategy

Hyper-crosslinked cyclodextrin porous polymer: an efficient CO<sub>2</sub> capturing material with tunable porosity

Hyper-crosslinked β-cyclodextrin porous polymer: an adsorption-facilitated molecular catalyst support for transformation of water-soluble aromatic molecules

Carbohydrate based hyper-crosslinked organic polymers with –OH functional groups for CO<sub>2</sub> separation

1,2-cis Alkyl glycosides: straightforward glycosylation from unprotected 1-thioglycosyl donors

ZnI2-Catalyzed Cyanation of Acyl Chlorides with TMS-CN: An Interesting Role of Iodine